ASX #8 CSL Limited

1.  Market Cap of AUD 87 billion. (8th largest ASX stock), Largest healthcare stock in Aus
2. Annual Revenue of USD 15.6 billion. Global biopharma company. Three key divisions
1. CSL Behring - Rare and serious diseases. USD 11.1 billion
2. CSL Seqirus - Influenza. USD  2.16 billion
3. CSL Vifor - Iron deficinecy USD 2.2 billion
3. 29000 global employees
4. Global Manufacturing Presence
5. Key players in vaccine (influenza) include Sanofi and GSK.
6. PAT 3.1 billion
7. Share price has been declining.

1.